COVID-19 Funding Opportunities
ORSP has identified the following funding opportunities related to COVID-19. If interested, please submit an NOI: research.utep.edu/noi
UTEP invites researchers are to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. The COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus. Applications are accepted at any time.
| Agency | Program | Due Date | Abstract | Type |
|---|---|---|---|---|
| United States Department of Health and Human Services (HHS) |
Biomedical Advanced Research and Development Authority (BARDA) Novel Coronavirus EZ-BAA |
Rolling | Seeks research for molecular diagnostic assays, point-of-care detection, screening models, and other topics pertaining to COVID-19. | FED |
|
White House Office of Science and Technology Policy |
This consortium is a unique private-public effort to bring together federal government, industry, and academic leaders to execute complex computational research programs. Researchers are invited to submit COVID-19 related research proposals to the consortium via this online portal, which will then be reviewed for matching with computing resources from one of the partner institutions. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. |
FED | ||
|
Food and Drug Administration (FDA)/Office of the Chief Scientist (OCS) |
The Food and Drug Administration (FDA) Office of the Chief Scientist (OCS) and FDA Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider applications for the award of a co-operative agreement to protect and promote the health of the American public by creating new, applied scientific knowledge, tools, standards and approaches to evaluate products more effectively, predictably and efficiently. |
FED | ||
|
National Endowment for the Humanities (NEH) |
Funding for NEH Applicants and Grantees Impacted by the Coronavirus |
|
FED | |
|
Office of the Assistant Secretary for Preparedness and Response (ASPR) |
Public Health Emergency development of new medical countermeasures |
Public Health Emergency development of new medical countermeasures |
FED | |
|
National Institutes of Health (NIH) Agency for Healthcare Research and Quality (AHRQ) |
The health systems research community should prepare to submit applications to AHRQ to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality, safety, and value of health system response to COVID-19, and the role of primary care practices and professionals during the COVID-19 epidemic. AHRQ is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations. |
SUPPL | ||
|
National Institutes of Health (NIH) |
To be announced |
The purpose of this Notice is to extend the data-harmonization effort at the National Institute of Mental Health (NIMH) announced in NOT-MH-15-009 to research protocols pertaining to the public health emergency caused by Coronavirus Disease 2019 (COVID-19), the disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
SUPPL | |
|
National Institutes of Health (NIH) |
Varies by program |
Three of the largest NIH parent/umbrella funding mechanisms have now been updated to indicate that applications pertaining to COVID-19 research are welcomed. |
FED | |
| National Institutes of Health (NIH) | Rolling | The National Institute of Allergy and Infectious Diseases (NIAID) has released a new funding opportunity to provide personal protective equipment to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 and the Coronavirus Aid, Relief and Economic Security (CARES) Act. | FED | |
|
National Institutes of Health (NIH) |
This Special Emphasis Notice (SEN) highlights AHRQ’s interest in receiving applications focusing on primary and other ambulatory care settings that: 1) test approaches to integrating organizational health literacy strategies that make it easier for people, especially those with limited health literacy, to take action to prevent and manage their chronic conditions, including diabetes, and 2) spread and scale previously tested organizational health literacy strategies to settings that serve a high proportion of patients with limited health literacy, and/or socioeconomically disadvantaged people.AHRQ is interested in applications that address:
|
FED | ||
|
National Institutes of Health (NIH) |
NIH Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19 |
Rolling |
The stimulus investment supercharges NIH’s strong research efforts already underway focused on prevention and treatment of COVID-19, including the recently announced planned Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership to coordinate the international research response to the pandemic. As part of this initiative, NIH is urging all scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development. The technologies will be put through a highly competitive, rapid three-phase selection process to identify the best candidates for at-home or point-of-care tests for COVID-19. |
FED |
|
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
These support research on SARS-CoV-2 and COVID-19. The maximum project period is five years. |
FED | ||
| National Institutes of Health (NIH) National Center for Advancing Translational Sciences(NCATS) |
01/02/2022 |
NCATS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the COVID-19. NCATS is especially interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines. |
SUPPL | |
| National Institutes of Health (NIH) National Cancer Institute (NCI) |
The National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer. | FED | ||
|
Agency for Health Care Research and Quality (AHRQ) |
Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement – Clinical Trial Optional) |
Varies |
For grants that were previously funded under FOAs supported by Patient Centered Outcome Research Trust Fund (PCOR TF) dollars, please see FOA number PA-20-072. For grants that were funded using AHRQ Health Service Research (HSR) dollars, please see FOA number PA-20-070. Topics: Applications must be responsive to AHRQ’s mission. AHRQ’s Research Priority Areas are:
|
SUPPL |
|
National Science Foundation (NSF) |
Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 | Rolling |
NSF is seeking Phase I SBIR/STTR proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. Topics: Artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. |
FED |
|
National Science Foundation (NSF) |
Rolling |
The NSF encourages investigators to use existing NSF funding mechanisms to submit proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.For proposals of up to $200K, NSF encourages using the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency. |
FED | |
| National Science Foundation (NSF) | Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) | Rolling |
The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. |
FED |
|
Department of Commerce (DOC) National Institute of Standards and Technology (NIST) |
NIST Manufacturing USA National Emergency Assistance Program | Rolling |
Topic: NIST invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic |
FED |
|
Department of Defense (DOD) |
Congressionally Directed Medical Research Programs (CDMRP) | Varies
|
Three of the FY20 PRMRP mechanisms are focused on Emerging Viral Diseases and Respiratory Health. Mechanisms: |
FED |
|
Department of Defense (DOD) Medical Technology Enterprise Consortium (MTEC) |
To be announced |
MTEC is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities, in cooperation with the U.S. Army Medical Research and Development Command (USAMRDC) and other DoD agencies in the biomedical sciences MTEC membership is not required for proposal submission, but it is required for an award. |
FED | |
|
Department of Defense (DOD) Medical Technology Enterprise Consortium (MTEC) |
National Emergency Telecritical Care Network (NETCCN) Project | To be announced |
This program is specifically focused on preparation for COVID-19 related critical care capability shortages. Although the United States has more critical care beds per capita than other developed nations, emerging national and international experience with COVID-19-related critical illness suggests a high level of oncoming system stress on critical care resources and a likely potential for intensive care unit (ICU) beds and care teams to be overwhelmed.
|
FED |
|
Department of Energy (DOE) |
DOE COVID-19 Response Letter | DOE encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Please send research questions that the scientific community may address with DOE resources by email to SC.DCL@science.doe.gov. More information can be found in the Dear Colleague Letter on DOE’s Coronavirus Resources Hub. | FED | |
|
Department of Energy (DOE) |
COVID-19 High Performance Computing Consortium | Rolling | Invites researchers are to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. The COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus. | FED |
|
US Department of Agriculture (USDA) |
National Institute of Food and Agriculture (NIFA) | Varies | In response to the current need for more COVID-19 information, certain NIFA programs will allow submission of COVID-19 relevant projects outside of their normal deadlines. Frequently Asked Questions regarding COVID-19 submissions can be found below. | FED |
| US Department of Agriculture (USDA) | Agriculture and Food Research Initiative (AFRI) | Varies |
Topics: Focus areas of interest include, but are not limited to the following:
|
FED |
|
National Institute of Standards and Technology (NIST) |
NIST Manufacturing USA National Emergency Assistance Program | Rolling | Projects should focus on responding to the COVID-19 pandemic. Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce. | FNDN |
|
Bill & Melinda Gates Foundation |
COVID-19 Therapeutics Accelerator |
The COVID-19 Therapeutics Accelerator is a collaborative effort to research, develop and bring effective treatments to market quickly and accessibly.Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and no proven treatments approved for use against COVID-19. The COVID-19 Therapeutics Accelerator is a philanthropic initiative designed to coordinate R&D efforts, remove barriers to drug development and scale up treatments to address the pandemic.We can combat COVID-19 together. Sharing knowledge and resources across governments, the private sector, academia and philanthropy can accelerate the timeline for bringing treatments to market. We are actively seeking and welcoming new partners and collaborators in this effort |
FNDN | |
|
California Institute for Regenerative Medicine |
Special Call for COVID-19 Projects | Rolling, Bi-monthly |
Topics: Discovery, preclinical, and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need. |
FNDN |
|
Emergent Ventures |
Fast Grants | Rolling |
Fast Grants are available exclusively to PIs at academic institutions already working on COVID-19 related projects that could help with the pandemic within the next six months. Topics: All COVID-19 related science |
FNDN |
|
Wellcome Trust |
Epidemic Preparedness - COVID-19 funding call | To be announced |
Wellcome, in partnership with the Department for International Development, invites expressions of interest for its epidemic preparedness - COVID-19 funding call. This aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and increase research and response capacity. |
FNDN |
|
Open Society Foundations |
To be announced |
The Open Society Foundations are making an investment to combat the devastation in the wake of the coronavirus—focusing on communities too often left out and left back by government policy. |
FNDN | |
| American Documentary | COVID-19 Artist Emergency Fund | Rolling |
This COVID-19 Artist Emergency Fund will provide rapid response grants up to $500 to assist artists with basic needs including food, immediate health needs and insurance premiums. Applications are now open and will be reviewed on a rolling basis until the fund is expired. These one-time grants are a direct response to concerns about sustainability in the documentary field, with overall lack of adequate healthcare alongside loss of livelihood due to canceled production, festivals and theatricals. |
FNDN |
|
Home Grown |
As our nation faces the COVID-19 pandemic, the importance of home-based child care has never been more evident and these caregivers and providers have never been more indispensable. We cannot fight this pandemic without ensuring that the essential workforce can access safe, high-quality child care. Without immediate action to maintain the supply of home-based child care, our near term efforts to rebuild the economy will likely be stalled. |
FNDN | ||
| Mozilla | COVID-19 Solutions Fund | Rolling | As part of the COVID-19 Solutions Fund, we will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation). | FNDN |
|
Chan Zuckerberg Initiative |
CZI COVID-19 Response | Rolling | Through our mission of supporting the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of this century — we are already making an impact in helping scientists and researchers on the frontlines of this outbreak. The work of CZI’s team is aimed at leveraging open science, technology, and collaboration to accelerate our shared understanding of COVID-19. And in collaboration with our partners and across our network of grantees, CZI is helping fight this virus by increasing access to testing, genomic sequencing, research, community support, and more. | FNDN |
|
Novartis |
Novartis COVID-19 Response Fund | To be announced | Novartis today announced a broad set of measures to support the global response to the COVID-19 pandemic. These measures include the creation of a global fund to support communities around the world impacted by the COVID-19 pandemic as well as the company’s decision to join two key cross-industry R&D initiatives. | FNDN |
| MusiCares | Rolling |
To help address the concerns of the industry during this time, we have expanded our services to include lost income due to the cancellation of scheduled gigs or performances due to Coronavirus/COVID-19 precautionary measures. |
FNDN | |
| Bill & Melinda Gates Foundation | To be announced |
The Bill & Melinda Gates Foundation, Wellcome and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently, there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on COVID-19. |
FNDN | |
| Patient-Centered Outcomes Research Institute (PCORI) | Rolling |
PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis through enhancements of currently funded PCORI research awards. |
FNDN | |
| Rolling |
A total of $20 million in Google Cloud research credits will be provided for leveraging Google’s computing capabilities and infrastructure to study therapies, vaccines, etc. |
FNDN | ||
| Amgen Foundation | Rolling |
Amgen has announced an open donation request program providing direct cash grants as well as lab supplies and equipment pertaining to COVID-19 relief; non-profits, IHEs, and health providers are welcome to apply. |
FNDN | |
|
CETF |
Research for COVID-19 Treatments | Rolling |
Topics: CETF seeks research funding to find an existing drug or drug combination that, when given early, can reduce COVID-19 hospitalization and fatality rates by 75% or more |
FNDN |
|
West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) |
West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) |
Rolling |
Topics: Pediatric medical device development or adaptation to manage the impact of COVID-19 on children |
FNDN |
|
Johnson & Johnson |
Topics: Proposals should address one or more of the following topics:
|
FNDN | ||
|
23andMe |
23andMe Research Innovation Collaborations Program for COVID-19 |
Rolling |
23andMe is now considering proposals focused on COVID-19. These proposals can include studies of outcomes, comorbidities, health disparities, and impacts of policies implemented to address the pandemic. If your proposal is related to COVID-19, please be sure to indicate this in your application. We are anticipating a high volume of COVID-19-related proposals, and our team of scientific reviewers is committed to selecting proposals where 23andMe’s participation will uniquely advance our understanding of this disease and the health of those impacted. |
FNDN |
|
Women’s History Network |
This supports historians of women who are suffering financial hardship because of the coronavirus. A total of eight awards, worth £400 each, are available. |
FNDN | ||
|
Spanish Ministry of Science and Innovation |
Solicitud Urgente de Expresiones de Interés para la Financiación Extraordinaria de Proyectos de Investigación sobre el SARS-CoV-2 y la Enfermedad COVID-19 (Spanish) |
Rolling |
Topics:
|
INTL |
|
Partnership for Advanced Computing in Europe |
|
This enables researchers to access computing resources to contribute to the mitigation of the impact of the COVID-19 pandemic. Access will be awarded for between three and six months and sized from 30 to 50 million core hours. |
INTL | |
|
Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) |
Emergency Action Projects to Combat the Effects of Covid-19 – FAPERJ / SES Partnership – 2020 |
Rolling |
Topics:
|
INTL |
|
National Research Council Canada |
National Research Council Industrial Research Assistance Program (NRC IRAP) |
Topics: Development of COVID-19 solutions for health care workers and public health officials Due Dates: None; applicants directly contact an Industrial Technology Advisor at NRC |
INTL |